Navigation Menu

Clinical Trial External Search


Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Thomas Riley III, MD, MS

Thomas Riley III, MD, MS

Professor, Department of Medicine
Division of Gastroenterology and Hepatology
Disease Teams:
Cancer Institute, Liver, Pancreas and Foregut Cancer Team
TRR5@psu.edu

Research Interests

  • Therapeutics
  • Liver
  • Liver Diseases
  • Liver Transplantation
  • Chronic Disease
  • Antiviral Agents
  • Hepatitis C
  • Chronic Hepatitis C
  • Hepacivirus
  • Fibrosis
  • Medicare
  • Biopsy

Recent Publications

2022

Tran, L, Jung, J, Feldman, R & Riley, T 2022, 'Disparities in the quality of care for chronic hepatitis C among Medicare beneficiaries', PloS one, vol. 17, no. 3 March, e0263913. https://doi.org/10.1371/journal.pone.0263913
Stine, JG, Schreibman, IR, Faust, AJ, Dahmus, J, Stern, B, Soriano, C, Rivas, G, Hummer, B, Kimball, SR, Geyer, NR, Chinchilli, VM, Loomba, R, Schmitz, K, Sciamanna, C, Strine, C, Wentzel, R, Marlin, S, Sica, C, Vesek, J, Eyster, E, Sinoway, L, Bentz, K, Handley, N, Hershey Fell, B, Mottilla, S, Christ, C, George, S, Novchich, T, Beyer, M, Clarke, K, Myers, T, Glading-Steinruck, M, Krok, K, Ma, T, Riley, T, Thompson, E, Tressler, H, Broach, J, Doan, T, Patrick, S, Reed, S, Hamilton, C, Slavoski, K & Tregea, D 2022, 'NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH', Hepatology, vol. 76, no. 1, pp. 172-185. https://doi.org/10.1002/hep.32274

2021

Tran, L, Feldman, R, Riley, T & Jung, J 2021, 'Association of the Extension for Community Healthcare Outcomes Project with Use of Direct-Acting Antiviral Treatment among US Adults with Hepatitis C', JAMA network open, vol. 4, no. 7, e2115523. https://doi.org/10.1001/jamanetworkopen.2021.15523
Du, P, Wang, X, Kong, L, Riley, T & Jung, J 2021, 'Changing Urban–Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014–2017', American Journal of Preventive Medicine, vol. 60, no. 2, pp. 285-293. https://doi.org/10.1016/j.amepre.2020.08.031
Kadry, Z, Schaefer, E, Krok, K, Faust, A, Stine, JG, Schreibman, IR, Bezinover, D & Riley, TR 2021, 'Excellent outcomes with liver transplantation in hepatopulmonary syndrome across pre-transplant PaO2 spectrum', JHEP Reports, vol. 3, no. 5, 100351. https://doi.org/10.1016/j.jhepr.2021.100351
Roy, J, Kang, M, Stern, B, Riley, T & Schreibman, I 2021, 'Lactulose-induced pneumatosis intestinalis following colonoscopy: a case report', Clinical Journal of Gastroenterology, vol. 14, no. 4, pp. 1152-1156. https://doi.org/10.1007/s12328-021-01392-9
Du, P, Jung, J, Kalidindi, Y, Farrow, K, Riley, T & Whitener, C 2022, 'Low utilization of direct-acting antiviral agents in a large national cohort of HIV and HCV coinfected Medicare patients in the United States: Implications for HCV elimination', Journal of Public Health Management and Practice, vol. 28, no. 2, pp. 130-134. https://doi.org/10.1097/PHH.0000000000001147
Noverati, N, Federici, E & Riley, TR 2021, 'Post-transfusion hemoglobin response in patients with cirrhosis: Can we expect a 1 g/dL rise per unit transfused?', Transfusion, vol. 61, no. 3, pp. 708-712. https://doi.org/10.1111/trf.16238
Kadry, Z, Stine, JG, Dohi, T, Jain, A, Robyak, KL, Kwon, O, Hamilton, CJ, Janicki, P, Riley, TR, Butt, F, Krok, K, Schreibman, IR, Bezinover, D, Ghahramani, N, Campos, S & Hollenbeak, CS 2021, 'Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial', Transplantation Direct, vol. 7, no. 7, pp. E709. https://doi.org/10.1097/TXD.0000000000001159

2020

Jung, J, Feldman, R, Kalidindi, Y & Riley, T 2020, 'Association of Direct-Acting Antiviral Therapy for Hepatitis C with After-Treatment Costs among Medicare Beneficiaries', JAMA network open, vol. 3, no. 6, pp. E208081. https://doi.org/10.1001/jamanetworkopen.2020.8081
Kalidindi, Y, Jung, J, Feldman, R & Riley, T 2020, 'Association of Direct-Acting Antiviral Treatment with Mortality among Medicare Beneficiaries with Hepatitis C', JAMA network open, vol. 3, no. 7, e2011055. https://doi.org/10.1001/jamanetworkopen.2020.11055
Jung, J, Du, P, Feldman, R & Riley, T 2020, 'Discontinuation of new hepatitis C drugs among Medicare patients', American Journal of Managed Care, vol. 26, no. 2, pp. 84-88. https://doi.org/10.37765/ajmc.2020.42397
Jain, A, Riley, TR, Krok, KL, Schreibman, I, Karamchandani, DM, Liao, X, Tian, Y, Dohi, T & Kadry, Z 2020, 'Incidence of post-liver transplant hepatic dysfunction after sustained virologic response following direct-acting anti-hepatitis c therapy', Experimental and Clinical Transplantation, vol. 18, no. 3, pp. 345-352. https://doi.org/10.6002/ect.2018.0127